IntelliProve, a Belgian company that measures vital signs through ordinary cameras, said on 19 November 2026 that it had raised €2.7m (about $3.0m) in seed funding led by the Belgian venture fund Miles Ahead.
The White and Yellow Cross (Wit-Gele Kruis in Dutch), a large Flemish home-nursing organisation, took part along with imec.istart and several business angels. The company did not disclose a valuation or headcount.
The round is IntelliProve's third reported raise. Tech.eu reported a €1m seed round in November 2022 and a €1.25m seed round led by Miles Ahead in January 2025. At the time of the 2025 round, Tech.eu said the company was operating in seven European countries, including Belgium, the Netherlands, the UK and Germany, with clients such as Helan and Neutraal Ziekenfonds Vlaanderen.
“Healthcare is at a tipping point. We believe the future of health monitoring is software-first, scalable and accessible to everyone.”Joeri Tulkens, co-founder and co-CEO, IntelliProve
What IntelliProve does
IntelliProve's software asks a user to look into a phone or laptop camera for 30 seconds and returns six biomarkers: heart rate, heart rate variability, respiratory rate, systolic and diastolic blood pressure, and resonant breathing. It relies on remote photoplethysmography, which picks up tiny changes in skin colour caused by blood flow, together with small breathing movements.
The company said it built three in-house technologies to handle movement, changing light and different cameras: VitalMesh, TripleGate and PulseShape. Its models have been tested on more than six million data points. Partners embed the scan in their own apps under their own brand, and IntelliProve said its technology is used by virtual care, health insurance and wellbeing platforms in more than 50 countries.
Founded in 2021 and based in Ghent, the company works with partners including TU Delft, Ghent University Hospital and The White and Yellow Cross. It said its software is CE marked and that it holds ISO/IEC 27001 certification.
From phones to robots
IntelliProve plans to take the same software to other devices with cameras, starting with humanoid and assistive robots that are moving into homes and care facilities. A robot could offer the person it is helping a short scan and pass the results on, with a human deciding what to do next. Tech.eu reported that the company is working with selected robotics partners and also sees uses in smart glasses and self-service kiosks.
Co-founder and chief technology officer Tanguy Sanglet said moving to new devices would not lower the company's standards for research, validation and data quality.
What the money is for
The company said the funding would extend its data to more skin tones, age groups, lighting conditions and devices, and improve accuracy one biomarker at a time, starting with blood pressure and heart rate variability. It will also pay for clinical research towards Class IIa certification under the EU Medical Device Regulation and for approvals outside Europe.
IntelliProve also plans to sign more virtual care partners and build ties with makers of humanoid and assistive robots.
Luc Burgelman, founder of Miles Ahead, said in the announcement that the company had built its technology with virtual care platforms in more than 50 countries and was now ready to scale, which was why his fund led the round.
Company website: intelliprove.com
